Fast 50 Technology Germany - ibidi Awarded for the 4th Consecutive Year

Munich, (PresseBox) - ibidi GmbH was awarded again this year by the Fast 50 competition!

For the forth year in a row, ibidi has received an award from the "Deloitte Technology Fast 50" competition. The Fast 50 is an awards program that honours companies that demonstrate exceptional business growth, technological innovation, and entrepreneurial spirit. The program ranks the 50 fastest-growing technology companies in Germany, based on their percentage of revenue growth over a five-year period. ibidi is the only Life Sciences company to be listed, and was again ranked in the top 50, out of more than 100 applicants.

"ibidi's cell-based assays are important scientific tools in the battle against cancer and disease", states Co-Founder and General Manager Dr. Roman Zantl. "Our high-innovative and high-qualitative products help our customers find a new path to the understanding and healing of a huge number of diseases. We are glad to see that our efforts have again bee appreciated, as we receive this respected prize."

ibidi's technology development is supported by the BMBF (Bundesministerium für Bildung und Forschung). Within the scope of joint research projects, ibidi continues to participate in the priority programs "KMU-Innovative", "Optical Technologies (Biophotonics)", and "Midi-Wing (Material innovation for industry and society)", all of which are run by the BMBF. "Our powerful growth would not have been possible without the intensive support of these research activities," declares Dr. Valentin Kahl, Co-Founder and General Manager at ibidi GmbH.

ibidi GmbH

ibidi® GmbH, located in Martinsried near Munich, Germany, is a leading supplier of functional, cell-based assays and products for cell microscopy. ibidi's range of products offers solutions for classic cell culturing, and also complex assays (e.g., angiogenesis, chemotaxis, and wound healing). Their products help facilitate an understanding of the development of various diseases, and related therapies. ibidi's customers are working, worldwide, in scientific institutions, industrial pharmacology, and biotechnology. The products are sold directly to customers, and are also distributed through international partners.

Press releases you might also be interested in

Weitere Informationen zum Thema "Forschung und Entwicklung":

Ein Blick in die Zukunft der Chatbots

Chat­bots bie­ten als di­gi­ta­le As­sis­ten­ten vie­le Vor­zü­ge in un­ter­schied­li­chen Ein­satz­ge­bie­ten, von der In­for­ma­ti­ons­re­cher­che über Kun­den­ser­vices bis hin zum On­li­ne­shop­ping. Doch ist die­se Tech­no­lo­gie nur ein kurz­fris­ti­ger Hy­pe?

Weiterlesen

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.